Protalix Historical Valuation

PLX Stock  USD 2.58  0.10  4.03%   
Some fundamental drivers such as market cap or Protalix Biotherapeutics enterprice value can be analyzed from historical perspective to project value of the company into the future. Some investors analyze Protalix Biotherapeutics valuation indicators such as to time the market or to short-sell their positions based on the trend in valuation ratios. It is a perfect tool to project the direction of Protalix Biotherapeutics's future value.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Protalix Biotherapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more information on how to buy Protalix Stock please use our How to Invest in Protalix Biotherapeutics guide.

About Protalix Valuation Data Analysis

Valuation is the financial process of determining what Protalix Biotherapeutics is worth. Protalix Biotherapeutics valuation ratios put that insight into the context of a company's share price, where they serve as useful tools for evaluating and utilizing investment potential. Protalix Biotherapeutics valuation ratios help investors to determine whether Protalix Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Protalix with respect to the benefits of owning Protalix Biotherapeutics security.

Protalix Biotherapeutics Valuation Data Chart

Market Cap is likely to drop to about 129.5 M in 2025. Enterprise Value is likely to drop to about 116 M in 2025

Enterprise Value

Enterprise Value (or EV) is usually referred to as Protalix Biotherapeutics theoretical takeover price. In the event of an acquisition, an acquirer would have to take on Protalix Biotherapeutics debt, but would also pocket its cash. Enterprise Value is more accurate representation of Protalix Biotherapeutics value than its market capitalization because it takes into account all of Protalix Biotherapeutics existing debt. A measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization that includes the market capitalization, plus total debt, minority interest and preferred shares, minus total cash and cash equivalents.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Protalix Stock Analysis

When running Protalix Biotherapeutics' price analysis, check to measure Protalix Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protalix Biotherapeutics is operating at the current time. Most of Protalix Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Protalix Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protalix Biotherapeutics' price. Additionally, you may evaluate how the addition of Protalix Biotherapeutics to your portfolios can decrease your overall portfolio volatility.